ImmuCell Corp (NASDAQ:ICCC)

During the Trading Day
4.85 +0.05 / +1.04%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.75 -0.10 / -2.06%
 
Volume: 200.00
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.5M

Company Description

ImmuCell Corp. is a biotechnology company, which develops, manufactures and sells products to improve animal health and productivity in the dairy and beef industry. Its products focuses on encompasses prevention, diagnosis and treatment of economically important bovine diseases. ImmuCell was founded by Frank E. Ruch in 1982 and is headquartered in Portland, ME.

Contact Information

ImmuCell Corp.
56 Evergreen Drive
Portland Maine 04103
P:(207) 878-2770
Investor Relations:

Employees

Shareholders

Other institutional5.48%
Individual stakeholders29.99%
Mutual fund holders2.95%

Top Executives

Michael F. BrighamPresident, CEO, CFO, Secretary & Treasurer
Joseph H. CrabbDirector, Chief Scientific Officer & VP

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.